SolveBio receives $2 million in funding

Posted May 14, 2014

SolveBio helps people use genomics to understand health by delivering reference data to genomics applications. Currently, most reference data is curated by academic institutions and is compiled in different formats, which makes it difficult for doctors and researchers to use. SolveBio announced today that it has raised $2 million from Andreessen Horowitz, Max Levchin, SV Angel, and several other investors.

By comparing a patient’s DNA to reference data, it will allow doctors to find other people with similar DNA variants and see how they were diagnosed and treated. SolveBio is building a system that can integrated genomics data into diagnostic and research applications and then will make it available as an API.

?SolveBio helps patients by making it possible to run diagnostic applications. Genetic diagnosis involves taking a person?s DNA and comparing it to the world?s information on the relationship between DNA and health,? stated CEO and co-founder Mark Kaganovich in an interview with TechCrunch. ?We provide that reference data in a simple, easy-to-use set of APIs. It?s ?clinical-grade? in that it is accurate, secure, up-to-date, and versioned (you know exactly what version of a dataset you are using).?

As more molecular data is collected from healthy and sick people in the future, health data startups will have to make sure that the information remains private and secure. SolveBio is partnering with other organizations to collect and distribute this data. Some people will want their data to be openly available and others want to monetize it. SolveBio is working with those requirements.